All Type of News
Health insurance reform
The National Health Insurance Corporation has recently unveiled five agendas to effectively cope with snowballing medication costs as an increasing number of patients are taking more expensive and diverse drugs.
Th...
Green Cross sets new milestone in overseas markets
Green Cross Corporation said Friday that it has signed a $68.48 million deal to build a plant of biological preparations in Thailand.
Under the deal with the Thai Red Cross Society, Green Cross will build the plant...
Hyundai Pharma sells Sunkist vitamin C tablets
Hyundai Pharmaceutical Co, said last Thursday it has launched Sunkist vitamin C tablets 1,000 mg and 500 mg for the exclusive sales of pharmacies.
Sunkist vitamin C tablets, which will be imported directly from Can...
Abbott completes split with AbbVie
Abbott Laboratories and its pharmaceutical spinoff AbbVie Inc. kicked off the year as separate companies.
AbbVie began trading Wednesday on the New York Stock Exchange under the symbol "ABBV.” The stocks had traded...
Dong-A sues Poolim Pharm over Stillen patent
Dong-A Pharmaceutical is suing Poonglim Pharmaceutical for violating its patent rights of Stillen, one of Dong-A’s flagship products for treatment of gastritis.
Dong-A said Thursday Poonglim has violated patent rig...
JW Pharma unveils Actemra
JW Pharmaceutical said Thursday it has started selling Actemra (tocilizumab) here, giving patients with rheumatoid arthritis (RA) access to the new antibody medication.
Actemra is an immunosuppressive drug, mainly ...
KPWA mulls tougher action against online drug shopping malls
The Korea Pharmaceutical Wholesaler Association (KPWA) is considering taking a tougher measure against the operation of five online drug shopping malls operated by drug makers.
The KPWA held a meeting on Thursday t...
HIRA adds five medicines subject to restricted use by gender
The state-run Health Insurance Review and Assessment Service on Thursday announced a list of five drugs whose restricted use will be additionally screened by gender starting from April
The drugs involved in the li...
All eyes are on emergence of second biosimilar
Industry officials say that the second biosimilar will be available in the first half of this year as Celltrion won approval to produce the world’s first antibody biosimilar, Resima in July 2012.
Remsima is a biosi...
Drug makers step up guard against crisis
Local drug manufacturers are placing priority on enhancing their financial structures and business portfolios to compete against much bigger foreign drug makers abroad by focusing on competitive new businesses like bi...
